Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2020 2
2021 3
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees.
Van Coillie J, Pongracz T, Rahmöller J, Chen HJ, Geyer CE, van Vught LA, Buhre JS, Šuštić T, van Osch TLJ, Steenhuis M, Hoepel W, Wang W, Lixenfeld AS, Nouta J, Keijzer S, Linty F, Visser R, Larsen MD, Martin EL, Künsting I, Lehrian S, von Kopylow V, Kern C, Lunding HB, de Winther M, van Mourik N, Rispens T, Graf T, Slim MA, Minnaar RP, Bomers MK, Sikkens JJ, Vlaar APJ, van der Schoot CE, den Dunnen J, Wuhrer M, Ehlers M, Vidarsson G; Fatebenefratelli-Sacco Infectious Diseases Physicians group; UMC COVID-19 S3/HCW study group. Van Coillie J, et al. Among authors: rahmoller j. EBioMedicine. 2023 Jan;87:104408. doi: 10.1016/j.ebiom.2022.104408. Epub 2022 Dec 16. EBioMedicine. 2023. PMID: 36529104 Free PMC article.
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.
Buhre JS, Pongracz T, Künsting I, Lixenfeld AS, Wang W, Nouta J, Lehrian S, Schmelter F, Lunding HB, Dühring L, Kern C, Petry J, Martin EL, Föh B, Steinhaus M, von Kopylow V, Sina C, Graf T, Rahmöller J, Wuhrer M, Ehlers M. Buhre JS, et al. Among authors: rahmoller j. Front Immunol. 2023 Jan 12;13:1020844. doi: 10.3389/fimmu.2022.1020844. eCollection 2022. Front Immunol. 2023. PMID: 36713457 Free PMC article.
Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions.
Epp A, Hobusch J, Bartsch YC, Petry J, Lilienthal GM, Koeleman CAM, Eschweiler S, Möbs C, Hall A, Morris SC, Braumann D, Engellenner C, Bitterling J, Rahmöller J, Leliavski A, Thurmann R, Collin M, Moremen KW, Strait RT, Blanchard V, Petersen A, Gemoll T, Habermann JK, Petersen F, Nandy A, Kahlert H, Hertl M, Wuhrer M, Pfützner W, Jappe U, Finkelman FD, Ehlers M. Epp A, et al. Among authors: rahmoller j. J Allergy Clin Immunol. 2018 Jan;141(1):399-402.e8. doi: 10.1016/j.jaci.2017.06.021. Epub 2017 Jul 18. J Allergy Clin Immunol. 2018. PMID: 28728998 Free PMC article. No abstract available.
Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions.
Petry J, Rahmöller J, Dühring L, Lilienthal GM, Lehrian S, Buhre JS, Bartsch YC, Epp A, Lunding HB, Moremen KW, Leliavski A, Ehlers M. Petry J, et al. Among authors: rahmoller j. J Allergy Clin Immunol. 2021 Feb;147(2):763-767. doi: 10.1016/j.jaci.2020.05.056. Epub 2020 Jun 27. J Allergy Clin Immunol. 2021. PMID: 32603664 Free PMC article. No abstract available.
Sialylation of IgE reduces FcεRIα interaction and mast cell and basophil activation in vitro and increases IgE half-life in vivo.
Dühring L, Petry J, Lilienthal GM, Bartsch YC, Kubiak M, Pfeufer C, Lehrian S, Buhre JS, Lunding HB, Kern C, Behrends J, Walsemann T, Gädert L, Sommer C, Krüger L, Blanchard V, Dehmel S, Jappe U, Rahmöller J, Ehlers M. Dühring L, et al. Among authors: rahmoller j. Allergy. 2023 Aug;78(8):2301-2305. doi: 10.1111/all.15665. Epub 2023 Feb 13. Allergy. 2023. PMID: 36724158 No abstract available.
Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study.
Balck A, Föh B, Borsche M, Rahmöller J, Vollstedt EJ, Waldeck F, Käding N, Twesten C, Mischnik A, Gillessen-Kaesbach G, Ehlers M, Sina C, Taube S, Busch H, Rupp J, Katalinic A, Klein C. Balck A, et al. Among authors: rahmoller j. BMC Public Health. 2022 Jul 7;22(1):1305. doi: 10.1186/s12889-022-13666-z. BMC Public Health. 2022. PMID: 35799167 Free PMC article.
One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk.
Klein C, Borsche M, Balck A, Föh B, Rahmöller J, Peters E, Knickmann J, Lane M, Vollstedt EJ, Elsner SA, Käding N, Hauswaldt S, Lange T, Hundt JE, Lehrian S, Giese J, Mischnik A, Niemann S, Maurer F, Homolka S, Paulowski L, Kramer J, Twesten C, Sina C, Gillessen-Kaesbach G, Busch H, Ehlers M, Taube S, Rupp J, Katalinic A. Klein C, et al. Among authors: rahmoller j. Sci Adv. 2022 Apr 15;8(15):eabm5016. doi: 10.1126/sciadv.abm5016. Epub 2022 Apr 15. Sci Adv. 2022. PMID: 35427158 Free PMC article.
Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients.
Schmelter F, Föh B, Mallagaray A, Rahmöller J, Ehlers M, Lehrian S, von Kopylow V, Künsting I, Lixenfeld AS, Martin E, Ragab M, Meyer-Saraei R, Kreutzmann F, Eitel I, Taube S, Käding N, Jantzen E, Graf T, Sina C, Günther UL. Schmelter F, et al. Among authors: rahmoller j. Front Mol Biosci. 2021 Dec 2;8:737039. doi: 10.3389/fmolb.2021.737039. eCollection 2021. Front Mol Biosci. 2021. PMID: 34938772 Free PMC article.
13 results